Aortic Dimensions in Patients With Fabry Disease

N/ANot Yet RecruitingNCT06956573

University Hospital, Caen200 enrolled

Overview

We will conduct a retrospective study aiming to define the characteristics, determinants, and progression of ascending aortic dilatation in adults with Fabry disease, using echocardiography and/or cardiac MRI

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Fabry Disease

Interventions

aorta imagingOTHER

Retrospective analysis of imaging data (echocardiography and/or cardiac MRI) in adult patients with Fabry disease to assess ascending aortic diameters.

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: a adult patients with genetically confirmed Fabry disease must be able to signed informed consent for participation in the study Exclusion Criteria: Patient refusal to participate in the study

Outcomes

Primary Outcomes

Maximum ascending aortic diameter measured by transthoracic echocardiography or cardiac MRI, expressed as a Z-score.

Time frame: At baseline

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.